China Imatinib Drugs Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Imatinib Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Cipla Inc

    • Novartis

    • Sun Pharmaceuticals

    • Glenmark Pharmaceuticals Ltd

    • Actavis Generics

    • Sanofi SA

    • Mylan Pharms Inc

    • Apotex Inc

    • Dr Reddy's Laboratories

    By Type:

    • Capsules

    • Tablets

    By Application:

    • Drug Stores

    • Hospitals

    • Other

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Imatinib Drugs Market Overview 2018-2029

    • 1.1 China Imatinib Drugs Industry Development Overview

    • 1.2 China Imatinib Drugs Industry Development History

    • 1.3 China Imatinib Drugs Industry Market Size (2018-2029)

    • 1.4 China Imatinib Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Imatinib Drugs Production Volume, Production Value and Growth Rate of Capsules (2018-2029)

      • 1.4.2 China Imatinib Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • 1.5 China Imatinib Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Drug Stores (2018-2029)

      • 1.5.2 China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

      • 1.5.3 China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • 1.6 China Imatinib Drugs Market Analysis by Region

      • 1.6.1 North China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Imatinib Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Imatinib Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Imatinib Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Imatinib Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Imatinib Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Imatinib Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Imatinib Drugs Industry Development

    Chapter 3 Imatinib DrugsIndustry Chain Analysis

    • 3.1 Imatinib Drugs Industry Chain

    • 3.2 Imatinib Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Imatinib Drugs Market

    • 3.3 Imatinib Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Imatinib Drugs Market

    Chapter 4 China Imatinib Drugs Market, by Type

    • 4.1 China Imatinib Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Imatinib Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Imatinib Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Imatinib Drugs Production Volume and Growth Rate of Capsules

      • 4.5.2 China Imatinib Drugs Production Volume and Growth Rate of Tablets

    Chapter 5 China Imatinib Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Imatinib Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Imatinib Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Imatinib Drugs Market Size and Growth Rate of Drug Stores

      • 5.5.2 China Imatinib Drugs Market Size and Growth Rate of Hospitals

      • 5.5.3 China Imatinib Drugs Market Size and Growth Rate of Other

    Chapter 6 China Imatinib Drugs Market, by Region

    • 6.1 China Imatinib Drugs Production Volume and Production Value, by Region

    • 6.2 China Imatinib Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Imatinib Drugs Market Analysis

    • 7.1 North China Imatinib Drugs Market, by Type

    • 7.2 North China Imatinib Drugs Market, by Application

    Chapter 8 Central China Imatinib Drugs Market Analysis

    • 8.1 Central China Imatinib Drugs Market, by Type

    • 8.2 Central China Imatinib Drugs Market, by Application

    Chapter 9 South China Imatinib Drugs Market Analysis

    • 9.1 South China Imatinib Drugs Market, by Type

    • 9.2 South China Imatinib Drugs Market, by Application

    Chapter 10 East China Imatinib Drugs Market Analysis

    • 10.1 East China Imatinib Drugs Market, by Type

    • 10.2 East China Imatinib Drugs Market, by Application

    Chapter 11 Northeast China Imatinib Drugs Market Analysis

    • 11.1 Northeast China Imatinib Drugs Market, by Type

    • 11.2 Northeast China Imatinib Drugs Market, by Application

    Chapter 12 Southwest China Imatinib Drugs Market Analysis

    • 12.1 Southwest China Imatinib Drugs Market, by Type

    • 12.2 Southwest China Imatinib Drugs Market, by Application

    Chapter 13 Northwest China Imatinib Drugs Market Analysis

    • 13.1 Northwest China Imatinib Drugs Market, by Type

    • 13.2 Northwest China Imatinib Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Cipla Inc

        • 14.1.1 Cipla Inc Company Profile

        • 14.1.2 Cipla Inc Imatinib Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Novartis

        • 14.2.1 Novartis Company Profile

        • 14.2.2 Novartis Imatinib Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Sun Pharmaceuticals

        • 14.3.1 Sun Pharmaceuticals Company Profile

        • 14.3.2 Sun Pharmaceuticals Imatinib Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Glenmark Pharmaceuticals Ltd

        • 14.4.1 Glenmark Pharmaceuticals Ltd Company Profile

        • 14.4.2 Glenmark Pharmaceuticals Ltd Imatinib Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Actavis Generics

        • 14.5.1 Actavis Generics Company Profile

        • 14.5.2 Actavis Generics Imatinib Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Sanofi SA

        • 14.6.1 Sanofi SA Company Profile

        • 14.6.2 Sanofi SA Imatinib Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Mylan Pharms Inc

        • 14.7.1 Mylan Pharms Inc Company Profile

        • 14.7.2 Mylan Pharms Inc Imatinib Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Apotex Inc

        • 14.8.1 Apotex Inc Company Profile

        • 14.8.2 Apotex Inc Imatinib Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Dr Reddy's Laboratories

        • 14.9.1 Dr Reddy's Laboratories Company Profile

        • 14.9.2 Dr Reddy's Laboratories Imatinib Drugs Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Imatinib Drugs Industry Research Conclusions

    • 15.2 Imatinib Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Imatinib Drugs Industry Market Size (2018-2029)

    • Figure China Imatinib Drugs Production Volume, Production Value and Growth Rate of Capsules (2018-2029)

    • Figure China Imatinib Drugs Production Volume, Production Value and Growth Rate of Tablets (2018-2029)

    • Figure China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Drug Stores (2018-2029)

    • Figure China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure China Imatinib Drugs Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure North China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Imatinib Drugs Market Size and Growth Rate from 2018-2029

    • Figure Imatinib Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Imatinib Drugs Market Share by Type in 2018

    • Figure China Imatinib Drugs Market Share by Type in 2023

    • Figure China Imatinib Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Imatinib Drugs Production Volume and Growth Rate of Capsules (2018-2023)

    • Figure China Imatinib Drugs Production Volume and Growth Rate of Tablets (2018-2023)

    • Figure China Imatinib Drugs Market Share by Application in 2018

    • Figure China Imatinib Drugs Market Share by Application in 2023

    • Figure China Imatinib Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Imatinib Drugs Market Size and Growth Rate of Drug Stores (2018-2023)

    • Figure China Imatinib Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Figure China Imatinib Drugs Market Size and Growth Rate of Other (2018-2023)

    • Table China Imatinib Drugs Production Volume by Region (2018-2023)

    • Table China Imatinib Drugs Production Volume Share by Region (2018-2023)

    • Figure China Imatinib Drugs Production Volume Share by Region (2018-2023)

    • Table China Imatinib Drugs Production Value by Region (2018-2023)

    • Table China Imatinib Drugs Production Value Share by Region (2018-2023)

    • Figure China Imatinib Drugs Production Value Share by Region (2018-2023)

    • Table China Imatinib Drugs Sales Volume by Region (2018-2023)

    • Table China Imatinib Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Imatinib Drugs Sales Volume Share by Region (2018-2023)

    • Table China Imatinib Drugs Sales Value by Region (2018-2023)

    • Table China Imatinib Drugs Sales Value Share by Region (2018-2023)

    • Figure China Imatinib Drugs Sales Value Share by Region (2018-2023)

    • Table North China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table North China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table North China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table North China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table Central China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table Central China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table South China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table South China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table South China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table East China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table East China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table East China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Imatinib Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Imatinib Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Imatinib Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Imatinib Drugs Sales Volume Share by Application (2018-2023)

    • Table Cipla Inc Company Profile

    • Table Cipla Inc Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceuticals Company Profile

    • Table Sun Pharmaceuticals Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Glenmark Pharmaceuticals Ltd Company Profile

    • Table Glenmark Pharmaceuticals Ltd Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Actavis Generics Company Profile

    • Table Actavis Generics Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Mylan Pharms Inc Company Profile

    • Table Mylan Pharms Inc Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Apotex Inc Company Profile

    • Table Apotex Inc Imatinib Drugs Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy's Laboratories Company Profile

    • Table Dr Reddy's Laboratories Imatinib Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.